In keeping with our hypothesis, we found that treatment of CLL cells with idelalisib resulted in a significant enhancement of spontaneous S1PR1 expression (Fig. 3A, Supplemental Fig. 2E). The gene discussed is S1PR1; the disease is B-cell chronic lymphocytic leukemia.